Publications
4536 Results
- Journal / Conference
- Blood Jan 3;133(1):81-93; Nov 16 [Epub ahead of print]
- Year
- 2019
- Research Committee(s)
- Lymphoma
- PMID
- PMID30446494
- PMC
- PMC6318431
- Study Number(s)
- S0016
Genomic Alterations Important for the Prognosis in Patients with Follicular Lymphoma Treated on SWOG Study S0016
- Journal / Conference
- JAMA Oncology Jan 17. doi: 10.1001/jamaoncol.2018.6437. [Epub ahead of print]
- Year
- 2019
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID30653226
- Study Number(s)
- S1204
The prevalence of HIV, Hepatitis B, and Hepatitis C among newly diagnosed cancer patients treated in academic and community oncology practices: SWOG S1204
- Journal / Conference
- Leukemia Research Jan 17;78:29-33
- Year
- 2019
- Research Committee(s)
- Leukemia
- PMID
- PMID30673620
- Study Number(s)
- S0106
The relationship between clinical trial accrual volume and outcomes in acute myeloid leukemia: A SWOG/ ECOG-ACRIN Study (S0106 and E1900)
- Journal / Conference
- European Urology Jan 4. pii: S0302-2838(18)31034-0. doi: 10.1016/j.eururo.2018.12.028. [Epub ahead of print]
- Year
- 2019
- Research Committee(s)
- Genitourinary
- PMID
- PMID30616946
- Study Number(s)
- S1011
What is the standard of care for pelvic lymphadenectomy performed at the time of radical cystectomy? [Editorial]
- Journal / Conference
- J Clin Oncol 37, 2019 (suppl 4; abstr 414); ASCO GI Cancers Symposium (Jan 17-19, 2019, San Francisco, CA), poster
- Year
- 2019
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S1505
SWOG S1505: Initial Findings on Eligibility and Neoadjuvant Chemotherapy Experience with mFOLFIRINOX versus Gemcitabine/nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma
- Journal / Conference
- Pharmacogenetics and Genomics Feb;28(2):49-55
- Year
- 2018
- Research Committee(s)
- Breast
- PMID
- PMID29278617
- PMC
- PMC5824720
- Study Number(s)
- S0221
Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci
- Journal / Conference
- Biology of Blood and Marrow Transplantation Apr;24(4):700-707
- Year
- 2018
- Research Committee(s)
- Lymphoma
- PMID
- PMID29289757
- PMC
- PMC5965270
- Study Number(s)
- S0410
Tandem autologous hematopoietic cell transplantation for patients with primary progressive or recurrent hodgkin lymphoma: a SWOG and Blood & Marrow Transplant Clinical Trials Network phase II Trial (SWOG S0410/BMT CTN 0703)
- Journal / Conference
- Oncology 94(1):39-46
- Year
- 2018
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID29040974
- PMC
- PMC5828967
- Study Number(s)
- CTSU/E2204
An intergroup randomized phase II study of bevacizumab or cetuximab in combination with gemcitabine and in combination with chemoradiation (capecitabine and radiation) in patients with resected pancreatic carcinoma: a trial of the ECOG-ACRIN Cancer Research Group (E2204)
- Journal / Conference
- Clinical Colorectal Cancer Mar;17(1):e121-e125; 2017 Oct 24 [Epub ahead of print]
- Year
- 2018
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID29233486
- Study Number(s)
- S0713
SWOG S0713: A phase II study of cetuximab added to induction chemotherapy of oxaliplatin and capecitabine, followed by neoadjuvant chemoradiation for locally advanced rectal cancer
- Journal / Conference
- Cancer Epidemiology Jun 21;55:117-122
- Year
- 2018
- Research Committee(s)
- Cancer Control and Prevention
- PMID
- PMID29936140
- PMC
- PMC Journal - In Process
- Study Number(s)
- S0000, SWOG-9217